The occurrence of terminal ileal histological abnormalities in patients with coeliac disease

• Published in: Digestive and liver disease Vol. 38; no. 11; pp. 815 - 819
• Main Authors: Hopper, A.D., Hurlstone, D.P., Leeds, J.S., McAlindon, M.E., Dube, A.K., Stephenson, T.J., Sanders, D.S.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.11.2006
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Case-Control Studies; Celiac Disease - immunology; Celiac Disease - pathology; Coeliac disease; Colonoscopy; Female; Humans; Ileum - immunology; Ileum - pathology; Intestinal Mucosa - immunology; Intestinal Mucosa - pathology; Intraepithelial lymphocytes; Lymphocyte Count; Lymphocytes - pathology; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Terminal ileal biopsy; Intraepithelial lymphocytes; Coeliac disease; Colonoscopy; Terminal ileal biopsy
• ISSN: 1590-8658; 1878-3562
• DOI: 10.1016/j.dld.2006.04.003

Coeliac disease causes histological changes throughout the small bowel, but is often a proximal lesion. We wanted to assess whether terminal ileal histological abnormalities occurred more commonly in patients with coeliac disease and if specific assessment of intraepithelial lymphocytes increases the recognition of undiagnosed coeliac disease. Terminal ileal biopsies were prospectively examined over a 3-year period (April 2001–May 2004). Patients were included if they were found to have a synchronous duodenal biopsy that gave a new diagnosis of coeliac disease ( n = 20). Terminal ileal biopsies taken at colonoscopy during the same period were also examined from four groups of patients: coeliac disease established on a gluten-free diet but with persisting symptoms ( n = 25), inflammatory bowel disease ( n = 47), chronic diarrhoea ( n = 44) and polyp surveillance ( n = 47). All biopsies were graded according to the Marsh criteria and an intraepithelial lymphocytes count per 100 enterocytes was obtained. There was only one patient from all five groups who had villous atrophy of the terminal ileal. This patient had a new diagnosis of coeliac disease. The mean intraepithelial lymphocytes count in the coeliac disease group was 23.7 intraepithelial lymphocytes/100 enterocytes. This was significantly higher than the control groups: coeliac disease on a gluten-free diet = 17.5 ( p < 0.012), inflammatory bowel disease = 12.3 ( p < 0.0001), diarrhoea = 12.6 ( p < 0.0001) and polyp = 13.7 ( p < 0.0002). Validating terminal ileal villous intraepithelial lymphocytes counts as a test for coeliac disease using an intraepithelial lymphocytes/100 enterocytes of >25 gives a sensitivity of 45% and a specificity of 97.8%. Routinely quantifying terminal ileal intraepithelial lymphocytes may be of limited clinical value. However, subjective recognition of raised intraepithelial lymphocytes on a terminal ileal biopsy should alert the clinician to the possibility of coeliac disease.